DCAT Member Company Community

What is industry capacity utilization for biomanufacturing among the major systems/platforms (mammalian, microbial, and advanced therapies)? Is there too much capacity or is the market tight? The latest episode of…

The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities.  Have a ESG news announcement…

Welcome to our Newest Member Companies! We are pleased to welcome the following companies to our DCAT Member Community. To View all DCAT member companies visit the Member Directory. From…

The latest ESG (environmental, social and governance) news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement…

What will be the key issues in the CDMO space for parenteral drug manufacturing in 2025? The latest episode of DCAT Value Chain Insights’ original podcast Production to Prescription, examines…

Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…

How are bio/pharma companies and their partners collaborating to resolve the difficult challenges that arise in development, manufacturing, and the supply chain? DCAT Member Companies are invited to apply to…

The DCAT Member Company Announcement Forum is a much-anticipated program at DCAT Week in which senior executives from DCAT Member Companies make major news announcements to DCAT Week’s influential attendees…

The bio/pharma industry plays a crucial role in developing the next generation of talent that will address today’s and tomorrow’s healthcare challenges.   The DCAT Science & Scholarship Committee, a volunteer…

What will be the key issues shaping bio/pharma supply chains in 2025? The latest episode of DCAT Value Chain Insights’ original podcast Production to Prescription, examines the latest hot-button issues: …